Understanding Adrenal Cancer with Reliable Facts and Treatment Options in India

If left untreated, adrenal cancer, an uncommon and frequently aggressive illness that affects the small glands above the kidneys-can disrupt the hormonal balance and cause serious health issues. Overproduction of these hormones can result from cancer that develops in the medulla or adrenal cortex, which can delay detection by producing symptoms that resemble those of other illnesses. Compared to more prevalent tumors, adrenal cancer is still poorly understood, with only 1-2 occurrences per million individuals occurring each year. However, improvements in genetics and targeted therapy are leading to better results.

Access to high-quality, reasonably priced care is crucial for patients with this diagnosis around the world. With cutting-edge cancer treatments that are 60-80% less expensive than those in Western nations, India has become a global leader in this field. As a premier medical tourism company, MediGence bridges the gap between patients and India's top hospitals. Founded on principles of transparency and patient empowerment, MediGence uses technology to provide tele-consultations, personalized treatment plans, and seamless logistics-from visa assistance to post-treatment recovery. You can connect with approved facilities through their Temos-certified portal, which guarantees 24/7 support and low rates. We'll go over trustworthy information regarding adrenal cancer in this comprehensive blog, including its symptoms, diagnosis, available treatments, developments, and why India is a great place to receive care thanks to MediGence.

What is Adrenal Cancer? Key Facts and Types

Adrenal cancer originates in the adrenal glands, triangular organs located above each kidney. The inner medulla of the glands secretes catecholamines like adrenaline, while the outer cortex generates steroids like cortisol and aldosterone. Although they are uncommon, malignant adrenal tumors can be fatal, but the majority are benign (non-cancerous adenomas).

About 80-90% of adrenal malignancies are of the most prevalent kind, adrenocortical carcinoma (ACC). It originates in the cortex and frequently generates excess hormones, which can result in diseases like Conn's syndrome (from excessive aldosterone) or Cushing's syndrome (from high cortisol). Usually benign but 10% malignant, pheochromocytoma arises in the medulla and raises blood pressure because of an overabundance of adrenaline. Although it is more common in youngsters, neuroblastoma can also affect the adrenal glands.

The exact causes of adrenal cancer are largely unknown, but genetic mutations play a significant role.

Alterations in genes like TP53 (linked to Li-Fraumeni syndrome) or IGF2 (in Beckwith-Wiedemann syndrome) increase risk. Environmental factors, such as exposure to carcinogens or smoking, may contribute, though evidence is limited. It primarily affects adults aged 40-50, with a slight female predominance, and children under 5 in rare cases. Hereditary syndromes have a higher incidence, which highlights the importance of genetic screening in families that are at risk. Its rarity is highlighted by trustworthy statistics: About 200-500 new cases are reported each year in the US; the 5-year survival rate for localized disease is 50-60%, but it drops to 20% if the disease spreads. Since tumors greater than 6 cm are more likely to be malignant, early diagnosis is crucial.

Symptoms and Risk Factors

It might be difficult to diagnose adrenal cancer early since its symptoms are frequently caused by hormonal imbalances rather than the tumor itself. About 60% of instances are caused by functioning tumors, or those that produce hormones.

Common symptoms include:

Abdominal pain or fullness: Due to tumor growth pressing on nearby organs.
Weight changes: Gain from cortisol excess (Cushing's: round face, buffalo hump) or loss from advanced disease.
High blood pressure: From aldosterone or catecholamine overproduction.
Excess hair growth or virilization: In women, from androgen excess; in men, feminization from estrogen.
Muscle weakness, fatigue, or diabetes: Linked to cortisol imbalances.
Palpitations, sweating, headaches: In pheochromocytoma.

Non-functioning tumors may remain asymptomatic until large, presenting with back pain or incidental findings on scans.

Risk factors are few but notable:

Genetic syndromes: Li-Fraumeni, Lynch, MEN1.
Family history of cancer.
Obesity or hypertension, though causal links are weak.
Radiation exposure in childhood.

Regular check-ups for those with risk factors can aid early detection.

Diagnosis of Adrenal Cancer

Diagnosing adrenal cancer involves a multi-step approach to differentiate malignant from benign tumors and assess spread.

The initial evaluation includes a thorough history and physical examination, with a focus on hormonal symptoms. Blood and urine tests measure hormone levels (cortisol, aldosterone, DHEA) and tumor markers.

Imaging is crucial:

CT or MRI: Detects tumor size, location, and invasion; contrast-enhanced for vascular details.
PET-CT: Uses FDG to identify metabolic activity in malignant cells.
Ultrasound: Less common but useful for initial screening.

Biopsy is controversial due to seeding risks, but may be performed via fine-needle aspiration if metastasis is suspected. Staging follows the ENSAT system: Stage I-II (localized), III (regional nodes), IV (distant mets).

Advanced tests are 70% less expensive in India than they are overseas. For example, MediGence offers virtual second opinions from oncologists for as little as USD 30-45.

Treatment Options for Adrenal Cancer

Treatment is multidisciplinary, tailored to stage, tumor function, and patient health. Surgery is the cornerstone, with adjuvant therapies for advanced cases.

Surgery: Adrenalectomy removal of the affected gland, is curative for localized tumors. Open surgery for large tumors; laparoscopic or robotic for smaller ones, minimizing recovery time. In metastatic disease, debulking reduces symptoms. Lymph node dissection may be included.
Chemotherapy: Mitotane, an adrenal-specific drug, is standard for ACC, often combined with etoposide, doxorubicin, and cisplatin (EDP-M protocol). It destroys adrenal cells but requires monitoring for side effects like nausea and liver toxicity.
Radiation Therapy: Used adjunctively for unresectable tumors or recurrence. Stereotactic body radiation (SBRT) targets precisely, sparing healthy tissue.
Targeted Therapy and Immunotherapy

Emerging options include tyrosine kinase inhibitors (e.g., cabozantinib) for vascular tumors and immune checkpoint inhibitors like pembrolizumab for high-mutation cases.

Hormone management with blockers (e.g., spironolactone) controls symptoms.

Advancements in Adrenal Cancer Treatment

As of 2025, research focuses on genomics and personalized medicine. Whole-genome sequencing identifies actionable mutations in 50% of ACC cases, enabling targeted drugs. Clinical trials explore IGF2 inhibitors and anti-angiogenic agents.

Minimally invasive robotics improves surgical precision, reducing complications by 30%. Liquid biopsies detect circulating tumor DNA for early recurrence monitoring.
Immunotherapy combinations show promise, with response rates up to 20% in advanced ACC. Stem cell research aims at regenerating adrenal function post-surgery.
These advancements boost survival, with 5-year rates now 65% for early-stage disease.

Treatment Options in India: Costs and Best Hospitals

India's oncology sector excels in adrenal cancer care, with JCI-accredited hospitals offering outcomes rivalling global standards at lower costs.

Surgery costs depends on the type of cancer (approximately $600 to $700 USD), chemotherapy ($600-700 per cycle), radiation ($770 to $3000 USD).

Treatment for adrenal cancer in India might cost anywhere from Rs. 80,000 to Rs. 20,000,000 (900- 23,000 USD). The type of treatment (surgery, chemotherapy, radiation, etc.), the hospital's location and amenities, and the cancer's stage and complexity are some of the reasons for this broad range.

Top hospitals:

English-speaking staff, short waits, and holistic care (yoga, nutrition) enhance recovery. Success rates: 90% for early-stage surgery.

How MediGence Can Help

MediGence simplifies medical tourism for adrenal cancer patients. Their platform offers:

Tele-Consultations: Connect with oncologists like Dr. Surender Kumar Dabas for USD 32-42.
Hospital Matching: Access top facilities with discounted rates.
Logistics: Visa, travel, accommodation, and interpreter services.
Post-Treatment: Rehabilitation and follow-up.

With partnerships across 15+ countries, focusing on India, MediGence has served 50,000+ patients, ensuring ethical, tech-driven care. For adrenal cancer, they prioritize hospitals with robotic capabilities and genetic expertise.

Conclusion

Despite being uncommon and difficult to treat, adrenal cancer can be controlled with early detection and cutting-edge therapies. Patients have optimism after learning the facts and investigating their options in India. MediGence facilitates this journey by lowering the cost and increasing access to top-notch care. For individualized recovery guidance, get in touch with MediGence right now if you have adrenal cancer.

Frequently Asked Questions

Recovery varies depending on the surgical approach and overall health. Minimally invasive procedures may allow recovery within 2-4 weeks, while open surgery can take longer. Full hormonal balance restoration may take several months and requires close medical monitoring.

A second opinion is recommended when the diagnosis is unclear, surgery is complex, or advanced treatments are being considered. Consulting another specialist for a second opinion can help confirm the treatment plan and provide confidence in decision-making.

Adrenal cancer is rarely detected in routine check-ups unless imaging tests are performed for other reasons. Many cases are found incidentally during scans for unrelated conditions, making advanced imaging like a CT scan, important for early detection.